Yıldız O, Karakurt Eryılmaz M, Aykut T, Genç Ömer, Kaya BE, Gürbüz AF. Reduced efficacy of nivolumab following prior immunotherapy in metastatic renal cell carcinoma: Implications for sequential immune checkpoint inhibition. Exp Biomed Res [Internet]. 2026 Jan. 1 [cited 2026 Jan. 2];9(1):1-9. Available from: https://www.experimentalbiomedicalresearch.com/index.php/ebr/article/view/527